The human tuberculosis vaccine market is influenced by several key dynamics. Firstly, the global burden of tuberculosis and the need for effective prevention drive the demand for vaccines. Additionally, government initiatives and funding to combat tuberculosis, especially in high-burden regions, play a crucial role. The presence of robust healthcare infrastructure and immunization programs in developed countries also impacts the market. Research and development activities focused on developing more efficient and safer vaccines contribute to market growth. However, challenges such as the complexity of tuberculosis biology, the need for multiple doses and booster shots, and the high cost of vaccine development and production can hinder market growth. Overall, the market is driven by the urgency to reduce tuberculosis incidence and mortality, but faces various scientific, economic, and logistical challenges.
Global Human Tuberculosis Vaccine Market is estimated to be valued at US$ 50.57 Mn in 2022 and is expected to exhibit a CAGR of 4.0% over the forecast period (2022-2030).
Prominent Players in the Human Tuberculosis Vaccine Industry:
1. GlaxoSmithKline Plc (GSK)
GSK was founded in 2000 and is headquartered in Brentford, United Kingdom. It is a global healthcare company that focuses on pharmaceuticals, vaccines, and consumer healthcare products. GSK operates in more than 150 countries worldwide, including the United States, China, India, and Brazil. In April 2022, GSK announced positive results from a Phase 2b trial of its investigational tuberculosis vaccine, showing encouraging efficacy and safety profiles
2. Merck & Co., Inc. (Merck)
Merck was founded in 1891 and is headquartered in Kenilworth, New Jersey, United States. It is a leading global pharmaceutical company that specializes in the development and production of vaccines, prescription medications, and animal health products. Merck operates in more than 140 countries worldwide, including the United States, Germany, Japan, and Brazil. In February 2023, Merck announced the initiation of a Phase 3 clinical trial for a novel tuberculosis vaccine candidate, aiming to evaluate its safety and efficacy.
3. Serum Institute of India Pvt. Ltd. (SII)
SII was founded in 1966 and is headquartered in Pune, India. It is the world's largest vaccine manufacturer and supplies vaccines to more than 170 countries. SII is primarily focused on producing affordable vaccines for diseases such as tuberculosis, measles, influenza, and COVID-19. In December 2021, SII announced the launch of a new tuberculosis vaccine called Vaxi-TB, which is based on the recombinant BCG (Bacillus Calmette-Guérin) technology.
4. Valneva SE
Valneva was founded in 2013 and is headquartered in Saint-Herblain, France. It is a specialty vaccine company that focuses on the development and commercialization of vaccines for infectious diseases. Valneva operates in several countries worldwide, including France, Austria, the United Kingdom, and the United States. In October 2022, Valneva announced the initiation of a Phase 3 clinical trial for its tuberculosis vaccine candidate, aiming to evaluate its safety and efficacy.
5. Archivel Farma
Archivel Farma was founded in 2007 and is headquartered in Barcelona, Spain. It is a biopharmaceutical company that specializes in the research and development of innovative vaccines and immunotherapies. Archivel Farma operates in multiple countries, including Spain, France, Italy, and the United States. As of the provided information, there are no specific recent developments regarding Archivel Farma's tuberculosis vaccine research.
6. BIOFABRI (Zendal)
BIOFABRI, also known as Zendal, was founded in 2001 and is headquartered in Porriño, Spain. It is a biopharmaceutical company that focuses on the development, production, and commercialization of vaccines. BIOFABRI operates in several countries worldwide, including Spain, France, the United States, and China. As of the provided information, there are no specific recent developments regarding BIOFABRI's tuberculosis vaccine research.
7. Japan BCG Laboratory
Japan BCG Laboratory was established in 1930 and is based in Tokyo, Japan. It is a research institution that specializes in the production and supply of Bacillus Calmette-Guérin (BCG) vaccines for tuberculosis. While it primarily operates within Japan, its BCG vaccines have been widely distributed and used globally for tuberculosis prevention. As of the provided information, there are no specific recent developments regarding Japan BCG Laboratory's tuberculosis vaccine research.
8. GreenSignal Bio Pharma Private Limited (GSBPL)
GSBPL was founded in 2005 and is headquartered in Chennai, India. It is a biotechnology company that focuses on the research, development, and production of vaccines. GSBPL primarily operates within India and has contributed significantly to the production of BCG vaccines for tuberculosis prevention. As of the provided information, there are no specific recent developments regarding GSBPL's tuberculosis vaccine research.
9. AJ Vaccines A/S
AJ Vaccines was founded in 2002 and is headquartered in Copenhagen, Denmark. It is a vaccine company that specializes in the development, production, and marketing of vaccines. AJ Vaccines operates in multiple countries, including Denmark, the United Kingdom, and the United States. As of the provided information, there are no specific recent developments regarding AJ Vaccines' tuberculosis vaccine research.
10. Taj Pharma India Limited
Taj Pharma India Limited was founded in 1995 and is headquartered in Mumbai, India. It is a pharmaceutical company that focuses on the research, development, and manufacturing of various medications, including vaccines. Taj Pharma operates primarily within India and exports its products to several countries worldwide. As of the provided information, there are no specific recent developments regarding Taj Pharma's tuberculosis vaccine research.
11. Biomed Lublin S.A.
Biomed Lublin S.A. was founded in 1944 and is headquartered in Lublin, Poland. It is a pharmaceutical company that specializes in the production of vaccines, immunological products, and medications. Biomed Lublin operates primarily in Poland and exports its products to various countries.
Definition- A human tuberculosis vaccine is a preventive medical intervention designed to stimulate the immune system and provide protection against tuberculosis, a contagious bacterial infection that primarily affects the lungs.
